Dr. Alexander Doctoroff, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1075 Central Ave, Clark, NJ 07066 Phone: 732-574-1399 Fax: 732-574-1433 |
News Archive
When the electronic health record is programmed to automatically flag and create orders for patients needing cancer screenings, doctors are significantly more likely to order them, a new Penn Medicine study shows. However, the study showed that the other part of the equation - patients following through on those screenings - was unaffected by the increase in orders.
ARICEPTĀ® a popular Alzheimer's drug has been shown to delay the onset of the disease among people with mild cognitive impairment.
Longing to find a cure for cancer, HIV and other yet incurable diseases, researchers have already tried out hundreds of drugs, each requiring preclinical and clinical testing with live subjects. How many chemical agents more to try? Moving at such rate, will we find the cure during our lifetime? One of the easiest ways to speed up the drug development process is to simply perform it outside of the living body (e.g., by watching the substances react with the smallest pieces of live tissue and thus quickly predicting the overall effect it will make to the body when inside).
A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies.
The National Institutes of Health has awarded Rush University Medical Center approximately $5.5 million in grants to study how epigenetic changes - chemical modifications to genes that result from diet, aging, stress, or environmental exposures - define and contribute to memory formation and cognitive decline. Results from the studies could profoundly alter the way the medical community understands, diagnoses, and treats Alzheimer's disease, according to the researchers.
› Verified 3 days ago